GlassScriptPhysician profile
Ashwinee Ragam
NPI 1811315278
$2,972.44
in general payments reported to CMS, 2019-2025
26 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $226 · 2021: $141 · 2022: $659 · 2023: $347 · 2024: $559 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $294.30 | 2019-2022 | |
| Alcon Vision LLC | $287.65 | 2019-2025 | Rocklatan, Hydrus Microstent, Tryptyr |
| Abbvie INC. | $253.35 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $235.31 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $213.08 | 2020-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $182.77 | 2019-2023 | |
| Glaukos Corporation | $178.75 | 2022-2024 | Idose |
| Bausch & Lomb Americas INC. | $152.34 | 2022-2025 | Xiidra, Vyzulta, Miebo |
| Mallinckrodt Enterprises LLC | $139.23 | 2019 | |
| Sight Sciences, INC. | $132.39 | 2022 | |
| Oyster Point Pharma, INC. | $118.55 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Kala Pharmaceuticals, INC. | $113.64 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $87.20 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $87.05 | 2019-2024 | Oxervate |
| Biotissue Holdings INC. | $85.14 | 2022-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $81.06 | 2022-2024 | Eylea |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $72.05 | 2019-2021 | |
| Eyepoint US, INC. | $61.77 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $55.86 | 2020 | |
| Coopervision INC. | $27.15 | 2025 | Misight Contact Lens |
| Ocular Therapeutix, INC. | $22.89 | 2019 | |
| Genentech USA, INC. | $21.00 | 2024 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $20.38 | 2024 | Syfovre |
| New World Medical,INC. | $17.75 | 2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Harrow Eye, LLC | $16.90 | 2025 | Triesence |
| Lensar, INC. | $14.88 | 2025 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwinee Ragam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.